Abstract 259P
Background
Borderline ovarian tumor(BOT) is a peculiar type of tumor with a favorable prognosis than the malignant tumors.There remains many gaps in our knowledge of the disease that result in controversies regarding their biology and different therapeutic approaches.The study aimed to evaluate the effect of suigical staging procedures on the prognosis and pregnant outcomes in the patients with BOTs.
Methods
We performed a retrospective analysis involving BOT patients who had underwent surgical staging procedures or not in West China Second University Hospital from January 2008 to January 2015 . The recurrence free survival (RFS)and pregnant outcomes were analysed using Kaplan-Meier method and Cox regression analysis, respectively.
Results
448 patients were included in the study with a median age of 35 years and median follow-up time of 113 months.Firty-two(11.6%)patients experienced relapse with the recurrent interval 80.2 months .Four(0.9%)patients died of the disease.118(26.3%)patients had undergone staging surgery while 330(73.7%) had done not.233 patients with fertility sparing surgery(FSS)attempted to conceive and 92(39.48%) achieved pregnancy.No significant difference of fertility outcomes were observed in the stagingsurgery or not groups(P = 0.691).In univariate analyses,staging surgery was obviously associated with RFS (HR = 2.191 P = 0.005),but was not an independent prognostic factor (p = 0.600) .Furthermore,the multivariate Cox analysis revealed that FIGO advanced stage(≥stage II), positive ascitescytologic washing and laparotomy were independent prognostic factors for RFS in the total population.
Conclusions
The BOT patients fail to benefit from surgical staging procedures in prognosis and fertility outcomes.When involved in early-stage (I),laproscope will be further rationally recommended to the patients with FSS than laparotomy.In addition, BOT patients with fertility desiring at advanced stage ,with invasive implants and bilateral tumors should choose FSS carefully.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
West China Second University Hospital,SiChuan Univeristy.
Funding
Has not received any funding.
All authors have declared no conflicts of interest.
Resources from the same session
64P - Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Presenter: Filippo de Braud
Session: Poster display session
Resources:
Abstract
65P - Updated efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
Presenter: Christian Rolfo
Session: Poster display session
Resources:
Abstract
66P - Brain metastases, treatment patterns and outcomes in ROS1-positive NSCLC patients from US oncology community centers
Presenter: Matthew Krebs
Session: Poster display session
Resources:
Abstract
67P - Pooled safety analysis of tepotinib in Asian patients with advanced solid tumours
Presenter: Kentaro Yamazaki
Session: Poster display session
Resources:
Abstract
68P - A novel anti-EGFR antibody HLX07 for potential treatment of squamous cell carcinoma of the head and neck
Presenter: Ming Mo Hou
Session: Poster display session
Resources:
Abstract
69P - Irinotecan and cisplatin therapy-induced neutropenia as a prognostic factor in patients with extensive-disease small cell lung cancer
Presenter: Hiroshi Ishikawa
Session: Poster display session
Resources:
Abstract
70P - Is safe and efficient by intraoperative endoscopic nasobiliary drainage over primary closure of the common bile duct for cholecystolithiasis combined with common bile duct stones: A meta-analysis
Presenter: Jiasheng Cao
Session: Poster display session
Resources:
Abstract
71P - Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A propensity score analysis
Presenter: Chaobin He
Session: Poster display session
Resources:
Abstract
72P - Novel technique of near-focus mode for accurate operation during endoscopic submucosal tunneling procedure: A two-center comparative study
Presenter: Wei Peng
Session: Poster display session
Resources:
Abstract
73P - Cabozantinib in combination with anti-PD1 immune checkpoint inhibitor in syngeneic tumour mouse models
Presenter: Rachel Sparks
Session: Poster display session
Resources:
Abstract